Get our free email newsletter

Novo Nordisk Recalls Insulin Delivery Devices

Global healthcare company Novo Nordisk has initiated a recall of certain insulin cartridge holders used in connection with the company’s NovoPen Echo®-brand insulin delivery devices.

According to an announcement made by the company in early July, the cartridge holders may crack or break if exposed to certain chemicals, such as cleaning agents. The defect could result in a patient receiving a reduced dose of insulin, resulting in higher than expected blood sugar levels.

Novo Nordisk says that it believes that the risk of experiencing a high blood sugar level when using a device with the recalled cartridge holder is low. However, the company has received numerous complaints of damaged cartridge holders, along with some reports of adverse events associated with the devices, thereby prompting the recall.

- Partner Content -

A Dash of Maxwell’s: A Maxwell’s Equations Primer – Part Two

Maxwell’s Equations are eloquently simple yet excruciatingly complex. Their first statement by James Clerk Maxwell in 1864 heralded the beginning of the age of radio and, one could argue, the age of modern electronics.

The recalled cartridge holders were distributed between August 2016 and June 2017.

Read the complete text of Novo Nordisk recall notice as posted to the FDA’s website.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, trending engineering news, and weekly recall alerts.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, trending engineering news, and weekly recall alerts.